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Abstract
BACKGROUND: Lycopene is an antioxidant that mostly found in daily ingredients such as tomatoes. Several studies 
have shown the lycopene potential in preventing prostate cancer. Nevertheless, the clinical use of lycopene as 
adjunctive therapy for prostate cancer is still under debate.
AIM: The objective of the study was to determine the effect of lycopene on human prostate cancer cell culture growth 
by measuring caspase-9 concentration as a marker of the intrinsic pathway of apoptosis in cells.
METHODS: This study was conducted on Indonesian prostate cancer cell culture from a patient with Gleason 
score 6, divided into 5 subgroups: 2 control groups and 3 treatment groups that were given 1 µM, 2 µM, and 4 µM of 
lycopene. Measurement of caspase-9 level was performed using enhanced chemiluminescence at 24, 28, and 72 h 
after lycopene addition in treatment groups. A comparative analysis was performed by two-way ANOVA.
RESULTS: The result showed that there was a significant difference of mean caspase-9 levels in the provision of 
various concentrations of lycopene and time of observation (p < 0.05). Increased of mean caspase-9 levels started 
at 2 µM dose of lycopene at 48 h and 4 µM at 24 h (p < 0.05) and continue to rise at 72 h, but caspase-9 was not 
detected at 1 µM dose in every observation.
CONCLUSION: There was a significant difference of mean caspase-9 levels in the provision of various concentrations 
of lycopene and time of observation.
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Introduction
Prostate cancer is the most common malignant 
disease of urology and also the most common 
noncutaneous malignancy in males. Globally, there 
were an estimated 782,600 new cases and 254,000 
cancer deaths in 2007 [1]. The incidence of prostate 
cancer in various Asian countries increases with a 
range of 5–118% [2]. Until present, the exact cause 
of prostate cancer is not known yet. However, some 
reports suggest that there are several risk factors for 
prostate cancer such as environment and genetic [3].
Another factor that plays an important role 
in the occurrence of prostate cancer is nutrition. 
Tambunan and Umbas reported that some nutrients 
had protective effects against the risk of prostate 
cancer, including tomato/lycopene, soy, cruciferous 
vegetables, green tea, and other polyphenolic 
compounds [4]. Several epidemiologic studies that 
observe groups of people with a low incidence of 
malignancy are conducted to determine and reduce 
the risk of prostate cancer. Vecchia; Rao and Agarwal; 
and Basu and Imrhan conducted several case-control 
studies in the period of 1983–1992, found that in 
a Mediterranean population, who consumed many 
fruits and vegetables, including tomatoes, had a low 
incidence of malignancy [5], [6], [7]. A case-control 
study in Minnesota found that people who consumed 
tomatoes more than 14 times/month had a lower risk of 
prostate cancer than those who ate tomatoes <3 times/
month [8]. Many studies concluded a protective effects 
of lycopene on prostate cancer [9], [8], [10], [11].
Siler et al. reported that lycopene increases the 
rate of necrosis in mice prostate cells. This corresponds 
to the decrease in local androgen regulatory signals 
and the expression of caspase-9 and interleukin 6 [12]. 
Tang et al. found that lycopene inhibited the growth of 
prostate cancer cells in vitro in male mice [13]. Research 
on humans reported by Obermuller-Jevic et al. found 
that lycopene inhibited the growth of normal human 
prostate epithelial cells in vitro (Prec-clone 6448) [14].
Lycopene became potential as a supplementary 
treatment for prostate cancer due to its known 
mechanism, typically inhibit the progressivity of cancer, 
that is, cell growth [15], [16]. Lycopene was expected to 
delay its progression and improve the survival rate of 
patients [7]. Although tomatoes are widely consumed 
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in Indonesia, there is no study regarding the effect of 
lycopene on prostate cancer in Indonesia. Hence, this 
study was conducted to determine the effect of lycopene 
on the level of caspase-9 in Indonesian human prostate 
cancer cell.
Materials and Methods
Materials
Materials of this study were tissues of prostate 
cancer obtained from prostate cancer patients admitted to 
DR. Hasan Sadikin General Hospital Bandung, who had 
undergone radical prostatectomy with the pathological 
result of Gleason score 6. Caspase-9 was measured 
using caspase-9 assay kit (Colorimetric) ab65608 Abcam.
Methods
The tissue obtained from radical prostatectomy 
then underwent a frozen section examination 
conducted by a pathologist to determine the location of 
prostate cancer. About 1 g of specimen was taken from 
area where shown positive for prostate cancer. The 
specimen with Gleason score of 6 was obtained after 
examined by a pathologist. It was placed in transport 
media contained a solution of Dulbecco’s modification 
of Eagle’s minimal essential medium (DMEM/F12) 
and antibiotic (penicillin100 U/mL, streptomycin 
100 µg/mL, amphotericin B 250 µg/mL, and gentamicin 
50 µg/mL) [17]. It was transported at a temperature of 
4°C to Biotechnology (Biotec) Laboratory in Rajawali 
Hospital, then underwent culture and subculture to 
attain enough number of cells to be utilized. The steps 
of the procedure were as follows:
1. Primary culture of prostate cancer (enzymatic 
disaggregation)
Primary prostate cancer cultures were 
prepared by incubation using 0.3% type 1 collagenase 
at 37°C. The results of the incubation were carried out 
by centrifugation at a speed of 2000 rpm to form pellets 
from prostate cancer. The incubation was carried out 
for 5–7 days with a temperature of 37°C and 5% CO2 
levels. After 5–7 days, the cells adhering to the bottom 
of the plate were observed under a microscope.
2. Cell multiplication method (subculture)
Cell propagation is done by dissociating cells from 
previous cultures. Cells were incubated after adding the 
Trypsin EDTA (Biosera) solution for 2–5 min. Cells were 
suspended and centrifuged at 2000 rpm for 5 min. The 
supernatant was removed; the pellets were implanted 
in 2–6 growth medium.
3. Histopathology examination
4. Prostate cancer cell treated with lycopene
The method of treating prostate cancer cell 
with lycopene was as below:
•	 Lycopene was dissolved in dimercaptosuccinic 
acid into 1 µM, 2 µM, and 4 µM concentrates
•	 Prostate cancer tissue culture was divided 
into 5 groups with 2 control groups (Group A 
and B) and 3 treated groups (Groups C, D, 
and E). Each group consisted of 500,000 cells 
(Figure 1).
Figure 1: Group of prostate cancer cell subculture
• Group A was neither treated with lycopene 
nor lycopene solvent
• Group B was not treated with lycopene but 
was given lycopene solvent
• Group C was treated with 1 µM lycopene 
[18]
• Group D was treated with 2 µM lycopene 
[19]
• Group E was treated with 4 µM lycopene.
• All groups were incubated at 37°C and in 5% 
CO2 for 24 h, 48 h, and 72 h.
5. Isolation of total protein from prostate cancer 
cell
6. Measurement of caspase-9 protein 
concentration by ELISA
Analysis was performed using a two-way 
analysis of variance (ANOVA) with the F test at a 
confidence interval of 95% using SPSS version 21.0 for 
Windows.
Results
The average increase in caspase-9 level 
compared to control (Group A and B) became visible 
after the administration of 2 µM lycopene (Group D) 
which occurs at the 48-h observation time. The level of 
caspase-9 increasing from 0.250 ng/ML to 0.635 ng/mL 
at the 72-h mark. Furthermore, the administration of 
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4 µM lycopene (group E) caused an increase in mean 
caspase-9 level compared to control after 24 h as 
much as 0.340 ng/mL, and continuously increased 
after 48- and 72-h observation time (0.585 ng/mL and 
0.605 ng/mL, respectively) (Table 1 and Figure 1).
Table 1: Mean caspase-9 levels based on lycopene 
concentration and observation time
Treatment 
group
Observation 
time
Average (SD) 
(ng/mL)
Range p-value*
1. Group A 24 H 0 0 F value (between 
treatment groups) = 
4694,86; p = 0.001 
(p < 0.05)
F-value (between 
observation times) = 
1458,067; p = 0.001 
(p < 0.05)
48 H 0 0
72 H 0 0
Combined 0 0
2. Group B 24 H 0 0
48 H 0 0
72 H 0 0
Combined 0 0
3. Group C 24 H 0 0
48 H 0 0
72 H 0 0
Combined 0 0
4. Group D 24 H 0 0
48 H 0.250 (0.0141) 0.240–0.260
72 H 0.635 (0.0212) 0.620–0.650
Combined 0.295 (0.2863) 0–0.650
5. Group E 24 H 0.340 (0) 0.340
48 H 0.585 (0.0071) 0.580–0.590
72 H 0.605 (0.0212) 0.590–0.620
Combined 0.510 (0.1324) 0.340–0.620
*Two-way ANOVA.
Discussion
The role of lycopene as an anti-cancer agent for 
prostate cancer has been widely reported [8], [9], [10], [11], [12]. 
This research used the culture of prostate cancer cell 
tissues from Indonesian patients that were given different 
dosages of lycopene with different observation times. The 
results obtained showed that lycopene had a decreasing 
effect on caspase-9 levels at a concentration of 2 µM within 
an observation time of 72 h and 4 µM within an observation 
time of 48 h [17]. From the evidence, it seems that with 
the increase amount of lycopene concentration, the faster 
the caspase-9 level decreases. This result is supported by 
several researchers such as Sapuntzakis and Bowen, who 
reported that the concentrations 0.1 µM, 0.5 µM, 1 µM, and 
5 µM can inhibit the LNCaP (this is not abbreviation, this 
is a name of cell) prostate cancer cell growth significantly. 
The cell cycle progress was also repressed by lycopene 
as proven by Palozza et al. lycopene at the concentration 
of 2.5 µM–10 µM could reduce the DI cyclin that plays a 
role in the G0/G1 and reduce the reactive oxygen species 
(ROS) production significantly [18], [19].
An interesting issue in this research was how 
the decrease of caspase-9 rate begins with an increase, 
whether it was given a lycopene concentration of 2 µM 
or 4 µM, as shown in Table 1. This incidence was not 
found in previous research. The average increase of 
the caspase-9 rate in the beginning of this study was 
thought to occur as an effect of the antioxidant that 
causes a high elimination of reactive oxygen species, 
till it disturbs the homeostatic rate of ROS that leads to 
cell damage and apoptosis.
High level of ROS might induce cell death and 
massive cell damage. High ROS level on cancer cell 
might cause failure in activating P38-MAPK bond which 
eventually leads to cancer cell death; hence, high ROS 
level acted as antiproliferation and apoptosis [20], [21]. This 
study showed that with prostatic cancer cell death after 
administration of 2 µM lycopene and 48 h of observation, 
there caused leakage of caspase-9 from intracellular to 
extracellular space, causing caspase-9 level to increase 
compared to the control group. This also occurred with 
the administration of 4 µM lycopene.
The mechanism of action of lycopene toward 
caspase-9 was by inhibiting transduction of DHT 
signaling which might suppress caspase-9 expression 
as elaborated by Liu et al. Dihydrotestosterone would 
bind with androgen receptor and then form a complex 
with beta-catenin to modulate the expression of several 
genes, including caspase-9 gene. Lycopene also 
increases serine phosphorylation effect on Akt and 
GSK3β, and tyrosine phosphorylation of GSK3, which 
might prevent cell growth [18]. Kanagaraj et al. stated 
that the administration of lycopene might induce the 
production of IGF binding protein-3 (IGFBP-3) which 
might cause a reduction of caspase-9. This caused 
inhibition of proliferation through MAPK pathway and 
PI3Akt [22]. This result was also established by Wang, 
who explained the mechanism of how lycopene might 
decrease caspase-9 level through inhibition of the 
insulin receptor phosphorylation process which was 
stimulated by caspase-9, expression of cyclin D1, 
and blockage of cell cycle which was stimulated by 
caspase-9, also increasing insulin growth factor binding 
protein (IGFBP); should the IGFBP level increase in 
blood, the protein would bind with caspase-9; thus, 
caspase-9 was unable to bind with its receptor [23].
This study showed that the administration of 
lycopene at 1 µM concentration had not affected the 
increase of mean caspase-9 level yet. This result was 
different with result from Hantz et al. [16], which stated 
that administration of physiologic concentration (0.3 µM 
and 1 µM) of lycopene might reduce the transmembrane 
potential of LNCaP cancer cell mitochondria, causing 
release of cytochrome C and eventually induce 
significant apoptosis [19]. Similar to Hantz et al., 
Sapuntzakis and Bowen reported the same results [24].
The average increase in caspase-9 level 
was observed during the administration of 2 µM and 
4 µM lycopene on each observation time. With 2 µM 
lycopene, the increase of caspase-9 occurred after 
48 h; meanwhile, with 4 µM lycopene, the increase had 
already been observed during the first 24 to 48 h and 
72 h of observation time. Similar result was also reported 
by Teodoro et al. that lycopene with a concentration of 
5 µM might reduce LNCaP, DU145, and PC3 cancer 
cell viability within 72 h and this result is parallel with 
the increase in lycopene concentration (10 µM and 
20 µM) [25]. Ford et al. reported that DU145 cancer 
cell proliferation could be inhibited with lycopene at 
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15 µM and 25 µM (supraphysiologic concentration) up 
to 10% and 19% respectively within 72 h; meanwhile, 
92–93% apoptosis occurred on the concentration of 
1 µM, 15 µM, and 25 µM within 72 h [26]. Teodoro et al. 
also reported that there was an increase in apoptosis of 
DU145 cancer cells after incubated with 3 µM lycopene 
for 96 h [25].
Lycopene with 2.5 µM, 5 µM, and 10 µM 
concentration might reduce AKT phosphorylation on 
prostatic LNCaP cancer cells. AKT was antiapoptosis, 
thus, reduction in AKT might increase Bax and Bak 
activation for apoptosis to happen. This result was 
explained using a study by Palozza et al. which stated 
that lycopene reduced expression of Bcl-2 and Bcl-xl 
significantly, both of which were known as antiapoptotic 
protein, and increase Bax which was a proapoptotic 
protein [27].
The limitation of this study was that observation 
time was limited to only up to 72 h; thus, it was 
assumed that the reduction of caspase-9 level has not 
yet reached the maximum level. Another limitation was 
that the proliferation of prostatic cancer cells through 
subculture did not achieve an appropriate number of 
cells to conduct repeated measurement for more than 
twice. Moreover, prostatic cancer tissues, which fulfilled 
inclusion criteria, were scarce; and calculation of the 
number of prostatic cancer cells (colony) based on 
concentration and observation time was not conducted 
after lycopene administration.
Conclusion
It could be concluded from this study that 
there was significant increase of caspase-9 levels 
on Indonesian human prostatic cancer cells by 
administration of various concentrations of lycopene 
and observation time. Lycopene could be administered 
as an adjuvant for advanced Gleason 6 stage prostatic 
cancer patients to increase apoptosis and eventually 
inhibit the progressivity of cancer cells.
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